{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:52:30Z","timestamp":1792785150849,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK092239"],"award-info":[{"award-number":["U01DK092239"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011684","name":"Crohn's and Colitis Foundation","doi-asserted-by":"publisher","award":["(P30 DK034987"],"award-info":[{"award-number":["(P30 DK034987"]}],"id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Crohn\u2019s and Colitis Foundation and the National Institutes of Health"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1053\/j.gastro.2018.06.046","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T03:31:44Z","timestamp":1530329504000},"page":"1098-1108.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis"],"prefix":"10.1053","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-823X","authenticated-orcid":false,"given":"Hans","family":"Herfarth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0235-0074","authenticated-orcid":false,"given":"John","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.R.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Osterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0308-1224","authenticated-orcid":false,"given":"Bincy","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond K.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-4537","authenticated-orcid":false,"given":"Gerald","family":"Dryden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-6172","authenticated-orcid":false,"given":"Monika","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Harlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-4744","authenticated-orcid":false,"given":"Campbell","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Polyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumona","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Yajnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-1547","authenticated-orcid":false,"given":"Jose","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2018.06.046_bib1","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1097\/MIB.0000000000000923","article-title":"Experts opinion on the practical use of azathioprine and 6-mercaptopurine in inflammatory bowel disease","volume":"22","author":"Mottet","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.06.046_bib2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1053\/j.gastro.2015.03.001","article-title":"Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus","volume":"148","author":"Bressler","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European Evidence-Based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: current management","volume":"11","author":"Harbord","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2018.06.046_bib4","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2017.16071","article-title":"Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease","volume":"318","author":"Lemaitre","year":"2017","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2018.06.046_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","article-title":"Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis","volume":"47","author":"Wessels","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.gastro.2018.06.046_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","article-title":"Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers","volume":"12","author":"Brown","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1053\/j.gastro.2018.06.046_bib7","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3899\/jrheum.141081","article-title":"Still trying to understand methotrexate","volume":"41","author":"Kremer","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1053\/j.gastro.2018.06.046_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohn's disease. The North American Crohn\u2019s Study Group Investigators","volume":"332","author":"Feagan","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2018.06.046_bib9","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A\u00a0comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn\u2019s Study Group Investigators","volume":"342","author":"Feagan","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2018.06.046_bib10","first-page":"CD003459","article-title":"Methotrexate for induction of remission in refractory Crohn\u2019s disease","volume":"2005","author":"Alfadhli","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2018.06.046_bib11","first-page":"CD006884","article-title":"Methotrexate for maintenance of remission in Crohn's disease","volume":"2009","author":"Patel","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2018.06.046_bib12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MPG.0b013e318196df3e","article-title":"Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues","volume":"48","author":"Weiss","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2018.06.046_bib13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/01.mib.0000235103.47280.bb","article-title":"Efficacy of methotrexate in pediatric Crohn\u2019s disease: a French multicenter study","volume":"12","author":"Uhlen","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.06.046_bib14","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1111\/j.1572-0241.2007.01474.x","article-title":"Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease","volume":"102","author":"Turner","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.06.046_bib15","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/gast.1996.v110.pm8613046","article-title":"Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial","volume":"110","author":"Oren","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MIB.0000000000000589","article-title":"Use of methotrexate in the treatment of inflammatory bowel diseases","volume":"22","author":"Herfarth","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.06.046_bib17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/ibd.21246","article-title":"Efficacy of methotrexate in ulcerative colitis: failure or promise","volume":"16","author":"Herfarth","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.06.046_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.gastro.2015.10.050","article-title":"Methotrexate is not superior to placebo for inducing steroid-free remission, but induces steroid-free clinical remission in a larger proportion of patients with ulcerative colitis","volume":"150","author":"Carbonnel","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.gastro.2016.02.085","article-title":"The METEOR Trial: the burial of methotrexate in ulcerative colitis?","volume":"151","author":"Macaluso","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MIB.0000000000000907","article-title":"Investigator-initiated IBD trials in the United States: facts, obstacles, and answers","volume":"23","author":"Herfarth","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.06.046_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A\u00a0review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis","volume":"132","author":"D'Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib22","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2018.06.046_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gut.2005.068809","article-title":"Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis","volume":"55","author":"Ardizzone","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2018.06.046_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2011.10.032","article-title":"Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis","volume":"142","author":"Sandborn","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2013.06.010","article-title":"Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis","volume":"146","author":"Sandborn","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/biomet\/68.1.316","article-title":"The asymptotic properties of nonparametric tests for comparing survival distributions","volume":"68","author":"Schoenfeld","year":"1981","journal-title":"Biometrika"},{"key":"10.1053\/j.gastro.2018.06.046_bib27","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1046\/j.1365-2036.2002.01340.x","article-title":"Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission","volume":"16","author":"Paoluzi","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.06.046_bib28","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1046\/j.1365-2036.1999.00667.x","article-title":"A\u00a0randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn\u2019s disease and ulcerative colitis","volume":"13","author":"Egan","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.06.046_bib29","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00042737-200012110-00010","article-title":"6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease","volume":"12","author":"Mate-Jimenez","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.06.046_bib30","first-page":"CD006618","article-title":"Methotrexate for induction of remission in ulcerative colitis","volume":"2007","author":"Chande","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2018.06.046_bib31","first-page":"CD007560","article-title":"Methotrexate for maintenance of remission in ulcerative colitis","volume":"8","author":"Wang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2018.06.046_bib32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2013.10.052","article-title":"Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis","volume":"146","author":"Panaccione","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ecco-jcc\/jjw004","article-title":"Systematic review and meta-analysis: placebo rates in induction and maintenance trials of ulcerative colitis","volume":"10","author":"Jairath","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2018.06.046_bib34","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2014.01.040","article-title":"Combination therapy with methotrexate in inflammatory bowel disease: time to COMMIT?","volume":"146","author":"Narula","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/j.gastro.2013.11.024","article-title":"Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn\u2019s disease","volume":"146","author":"Feagan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib36","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/apt.13387","article-title":"Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis","volume":"42","author":"Jharap","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.06.046_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/bmj.305.6844.20","article-title":"Randomised controlled trial of azathioprine withdrawal in ulcerative colitis","volume":"305","author":"Hawthorne","year":"1992","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2018.06.046_bib38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","author":"Lin","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.06.046_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2015.09.001","article-title":"Correlation between concentrations of fecal calprotectin and outcomes of patients with ulcerative colitis in a phase 2 trial","volume":"150","author":"Sandborn","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.06.046_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2013.03.025","article-title":"The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis","volume":"145","author":"Feagan","year":"2013","journal-title":"Gastroenterology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508518346882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508518346882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:20:09Z","timestamp":1758036009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508518346882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0016508518346882"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2018.06.046","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2018.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the AGA Institute","name":"copyright","label":"Copyright"}]}}